Drug policy in the USA is in constant flux. While some states are advancing progressive measures, other initiatives are failing due to formal obstacles. This shows that the legalization debate remains polarized and has different priorities depending on the region. For us in Switzerland, this international development is interesting because it shows how different countries approach cannabis and substance policy.
In Switzerland, we have chosen our own path with a regulated market for CBD products. Our customers benefit from strict quality standards and transparent regulations – particularly with our THC limit of a maximum of 1%. This allows us to offer high-quality CBD products that fully comply with Swiss laws and are reliable.
International discussions underscore how important factual, evidence-based debates on drug policy are. At GreenShop, we focus on transparency, quality, and compliance with all legal requirements. Would you like to learn more about our products and their legal basis? We are happy to advise you. Source: Marijuana Moment (marijuanamoment.net)
